Phibro Animal Health (PAHC) Stock Price Down 8.3% After Earnings Miss

Phibro Animal Health Corp (NASDAQ:PAHC) traded down 8.3% during trading on Wednesday following a dissappointing earnings announcement. The company traded as low as $35.37 and last traded at $38.70. 516,384 shares changed hands during trading, an increase of 354% from the average session volume of 113,693 shares. The stock had previously closed at $42.18.

The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.03). Phibro Animal Health had a return on equity of 39.81% and a net margin of 7.90%. The company had revenue of $200.20 million during the quarter, compared to analyst estimates of $203.99 million. During the same quarter in the prior year, the company posted $0.38 earnings per share. The business’s revenue was up 3.5% compared to the same quarter last year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Stockholders of record on Wednesday, November 28th will be issued a $0.12 dividend. This is a positive change from Phibro Animal Health’s previous quarterly dividend of $0.10. This represents a $0.48 annualized dividend and a dividend yield of 1.24%. The ex-dividend date of this dividend is Tuesday, November 27th. Phibro Animal Health’s dividend payout ratio is currently 22.99%.

Several equities analysts have recently commented on the stock. BidaskClub lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, August 16th. Zacks Investment Research lowered shares of Phibro Animal Health from a “hold” rating to a “strong sell” rating in a report on Wednesday, October 24th. Finally, Morgan Stanley upped their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a report on Wednesday, August 29th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $43.20.

In other Phibro Animal Health news, insider Dean J. Warras sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $42.84, for a total transaction of $428,400.00. Following the sale, the insider now directly owns 10,000 shares in the company, valued at approximately $428,400. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Daniel M. Bendheim sold 2,500 shares of the stock in a transaction that occurred on Wednesday, September 12th. The stock was sold at an average price of $44.30, for a total transaction of $110,750.00. Following the sale, the vice president now owns 2,500 shares in the company, valued at $110,750. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 143,020 shares of company stock worth $6,967,571. 50.29% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in PAHC. Dimensional Fund Advisors LP lifted its holdings in Phibro Animal Health by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 482,718 shares of the company’s stock worth $19,164,000 after buying an additional 4,674 shares in the last quarter. Royal Bank of Canada lifted its holdings in Phibro Animal Health by 2,104.6% during the 1st quarter. Royal Bank of Canada now owns 3,814 shares of the company’s stock worth $151,000 after buying an additional 3,641 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Phibro Animal Health by 2.6% during the 1st quarter. Principal Financial Group Inc. now owns 160,503 shares of the company’s stock worth $6,372,000 after buying an additional 4,116 shares in the last quarter. Allianz Asset Management GmbH lifted its holdings in Phibro Animal Health by 40.7% during the 1st quarter. Allianz Asset Management GmbH now owns 109,604 shares of the company’s stock worth $4,352,000 after buying an additional 31,694 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC lifted its holdings in Phibro Animal Health by 17.6% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 11,371 shares of the company’s stock worth $524,000 after buying an additional 1,700 shares in the last quarter. Institutional investors own 47.95% of the company’s stock.

The firm has a market capitalization of $1.71 billion, a PE ratio of 22.24, a P/E/G ratio of 3.55 and a beta of 0.82. The company has a current ratio of 2.90, a quick ratio of 1.66 and a debt-to-equity ratio of 1.62.

ILLEGAL ACTIVITY NOTICE: “Phibro Animal Health (PAHC) Stock Price Down 8.3% After Earnings Miss” was originally posted by WKRB News and is owned by of WKRB News. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.wkrb13.com/2018/11/08/phibro-animal-health-pahc-stock-price-down-8-3-after-earnings-miss.html.

Phibro Animal Health Company Profile (NASDAQ:PAHC)

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: Cost of Capital Explained

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply